我国临床联合西药治疗甲减应用进展  

Progress in Clinical Application of Combined Western Medicine in Treating Hypothyroidism in China

作　　者：孙博[1] 曲义坤[1] Sun Bo;Qu Yikun(General Surgery,Jiamusi University,Heilongjiang Jiamusi,154000)

机构地区：[1]佳木斯大学普通外科,黑龙江佳木斯154000

出　　处：《化工时刊》2021年第4期28-31,共4页Chemical Industry Times

摘　　要：甲减即甲状腺功能减退症,一类临床较为常见的内分泌系统疾病,是由于甲状腺激素合成,分泌下降或生物效应较差从而引发的机体生理代谢低下综合征,影响患者生命健康和日常生活,随着我国医疗水平的日益发展,对甲减的治疗有着不断地认识,单用某种药物有时会发生不良反应或治疗效果不理想,因此联和药物治疗逐渐发展起来,甲减目前主要通过西药治疗且大多数临床试验均在国外进行,现就我国联合西药治疗甲减应用进展做一综述。Hypothyroidism is a kind of common endocrine system disease in clinic.It is a syndrome of low physiological metabolism caused by decreased synthesis and secretion of thyroid hormone or poor biological effect,which affects patients'life and health and daily life.With the development of medical treatment in China,there is a constant understanding of the treatment of hypothyroidism.Sometimes adverse reactions or unsatisfactory therapeutic effects will occur when a certain drug is used alone,so combined drug treatment is gradually developed.At present,hypothyroidism is mainly treated by western medicine and most clinical trials are conducted abroad.

关 键 词：甲状腺功能减退症 甲减性心脏病 甲减性脑损伤 甲减性精神障碍 甲减性焦虑抑郁 

分 类 号：R4.6[医药卫生—临床医学]